Archives

Major Depressive Disorder In Chronic Kidney Disease
There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD.
*Speakers are employees or paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Featured Speakers

Becky Wong, PharmD, MBA
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Areas of Expertise:
- Psychiatry
- Community / Clinical Pharmacy
- Health Care Management
- Medication Therapy Management
- Managed Care

Kaitlin Dehlin, PhD, RD*
Kaitlin Dehlin, PhD, RD earned her doctorate from West Virginia University in Animal and Nutritional Sciences. Her doctoral work examined various dietary interventions to attenuate disease progression in a preclinical rat model of polycystic kidney disease. Prior to that, Dr. Dehlin earned a master’s degree and worked clinically as a Registered Dietitian. Since the completion of her doctorate in 2014, Dr. Dehlin joined Mead Johnson Nutrition and worked on various products and clinical trials. She joined Otsuka in 2018 as a Medical Science Liaison. During her time at Otsuka, she has built relationships with key opinion leaders, assisted in resource development, and worked with several clinical trial sites.